Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.67 USD | -2.65% |
|
-13.62% | -11.11% |
01/07 | Relmada Therapeutics, Inc.(NasdaqGS:RLMD) added to Russell Microcap Growth Index | CI |
01/07 | Relmada Therapeutics, Inc.(NasdaqGS:RLMD) added to Russell 3000E Growth Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.11% | 114M | |
+19.65% | 126B | |
+22.98% | 118B | |
+23.26% | 27.87B | |
-19.15% | 20.95B | |
-15.13% | 16.92B | |
-14.35% | 16.18B | |
+9.42% | 14.84B | |
-46.10% | 14.79B | |
+50.64% | 14.08B |
- Stock Market
- Equities
- RLMD Stock
- News Relmada Therapeutics, Inc.
- Transcript : Relmada Therapeutics, Inc., Q1 2021 Earnings Call, May 12, 2021